Tags : Parkwalk Advisors

Series B

Brainomix secures £16 million Series B investment from Boehringer Ingelheim

OXFORD, UK, 16th December, 2021 – Brainomix, the AI-powered medtech solutions company, today announces that it has closed a series B financing round, raising £16M ($21.2M) to fund its expansion into new markets and new therapeutic indications, including lung fibrosis and cancer. This investment will build on the proven success of the company’s tech platform in stroke […]Read More

IT Services

Arkivum secures £1.5 million Growth Private Equity investment led by

Growthdeck-led fundraise for digital archivers Arkivum closes at over £1.5m Arkivum is partnering with Google to deliver a €4.8m data archiving project   Private equity investment firm Growthdeck – alongside existing investors, IP Group and Parkwalk – has closed a £1.575m fundraise for the secure digital archiving platform Arkivum.  Arkivum helps businesses ensure that the […]Read More

Series A

Mogrify secures £12.25 million Series A Follow On investment led

Mogrify completes Series A financing totaling $33 million USD Second close of $17 million USD brings total raised in Series A to $33 million USD Funding led by Parkwalk Advisors with participation from strategic investor: Astellas Venture Management, as well as 24Haymarket, Dr Jonathan Milner and Dr Darrin M Disley OBE Funding will support advancement of immuno-oncology and ophthalmology programs […]Read More


HexagonFab secures £1.9 million Seed investment led by Cambridge Enterprise

HexagonFab secures £1.9m seed funding to launch the Bolt, an analytical lab instrument to speed discovery and production of next-generation biopharmaceuticals The Bolt provides convenient and affordable access to molecular binding analytics Cambridge, April 20, 2021 ­– University of Cambridge spin-out company HexagonFab today announces a £1.9 million seed funding round, led by Cambridge Enterprise, […]Read More

South East

Oxford Endovascular secures £7.28 million Series A investment from investors

Oxford Endovascular Ltd raises $10m to develop an origami engineered medical device to prevent brain haemorrhage Funding will support the company to achieve first in-human data Oxford, UK, 8th April 2021 – Oxford Endovascular, a pioneering British MedTech company and spin-out from Oxford University, is developing a treatment for brain aneurysms, that will overcome challenges […]Read More


PhoreMost secures £33 million Series B investment led by BGF

PhoreMost closes £33M ($46M) Series B financing Funding to support progression of PLK1 program, for treatment of brain cancer, into the clinic within 18 months Company is advancing its pipeline of novel therapies for oncology and diseases of ageing, and developing novel therapeutic modalities in the targeted protein degradation space Oversubscribed investment round led by BGF, […]Read More


Legislate Technologies secures £1 million Seed investment led by Parkwalk

Legislate Technologies secures £1m to help simplify contracting for businesses and landlords using knowledge graph technology Funding will go towards accelerating product development and launch in the UK market Oxford, 11 March 2021– Legislate Technologies, a legal technology startup building a SaaS platform to enable small businesses and landlords to easily create, sign, and manage […]Read More


Cambridge GaN Devices secures £6.8 million Series A investment co-led

Cambridge GaN Devices raises $9.5m Series A to accelerate the deployment of energy efficient devices reshaping the future of power electronics Cambridge University spinout’s latest funding round will be used to double staff and expand its GaN product portfolio following decades of research in power devices Cambridge, 18th February 2021 – Cambridge GaN Devices (CGD) has raised […]Read More


Charco Neurotech secures £500k Seed investment led by Parkwalk Advisors

Imperial College fund makes first investment into tech startup tackling Parkinson’s disease The Imperial College Innovation Fund is managed by leading university spinout fund manager Parkwalk London, 3 February 2020: The Imperial College Innovation Fund (ICIF), an early-stage investment fund launched at Imperial in early 2020 and managed by Parkwalk Advisors to invest in early-stage, high-growth, knowledge-intensive companies, has completed its first investment […]Read More